BOSTON, April 4, 2024 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced today that it has received 510(k) clearance from the U.S. Food and Drug…
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis – HN Cartridge
This post was originally published on this site